Nov 17 (Reuters) - MedCap AB (publ) MEDCAP.ST :
* MEDCAP AB (PUBL) ANNOUNCES A RECOMMENDED CASH OFFER AT A
PRICE
OF SEK 3.60 PER SHARE TO THE SHAREHOLDERS OF ADDERACARE AB
(PUBL)
* MEDCAP OFFERS SEK 3.60 IN CASH PER SHARE IN ADDERACARE,
WHICH
REPRESENT A TOTAL VALUE OF OFFER
* OFFER REPRESENTS A PREMIUM OF APPROXIMATELY:* 18.0 PER
CENT
COMPARED TO CLOSING PRICE OF SEK 3.05 FOR ADDERACARE SHARE ON
NASDAQ FIRST NORTH GROWTH MARKET ON 16 NOVEMBER 2022
* - MEDCAP OFFERS SEK 3.60 IN CASH PER SHARE IN ADDERACARE,
WHICH
REPRESENT A TOTAL VALUE OF OFFER, BASED ON ALL 33,716,835
OUTSTANDING SHARES IN ADDERACARE, OF APPROXIMATELY SEK 121
MILLION
* BOARD OF DIRECTORS OF ADDERACARE HAS UNANIMOUSLY DECIDED
TO
RECOMMEND SHAREHOLDERS OF ADDERACARE TO ACCEPT OFFER
* ACCEPTANCE PERIOD FOR OFFER IS EXPECTED TO BEGIN ON OR
ABOUT 2
DECEMBER 2022 AND EXPIRES ON OR ABOUT 23 DECEMBER 2022
* MEDCAP DOES NOT EXPECT OFFER TO HAVE A SIGNIFICANT IMPACT
ON
LOCAL OPERATIONS OF ADDERACARE'S SUBSIDIARIES, INCLUDING
MANAGEMENT TEAMS AND EMPLOYEES AND THEIR EMPLOYMENT TERMS
* LINC, WHOSE TOTAL OWNERSHIP AMOUNTS ABOUT 24.36% OF SHARES
AND
VOTES IN ADDERACARE, STATED THAT IT IS IN FAVOUR OF AND SUPPORTS
COMPLETION OF OFFER
Source text for Eikon: ID:nWkrbQN0Zl
Further company coverage: MEDCAP.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))